DE3577230D1 - Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer. - Google Patents

Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.

Info

Publication number
DE3577230D1
DE3577230D1 DE8585306916T DE3577230T DE3577230D1 DE 3577230 D1 DE3577230 D1 DE 3577230D1 DE 8585306916 T DE8585306916 T DE 8585306916T DE 3577230 T DE3577230 T DE 3577230T DE 3577230 D1 DE3577230 D1 DE 3577230D1
Authority
DE
Germany
Prior art keywords
phase
substances
determining
formation
distinct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585306916T
Other languages
English (en)
Inventor
Larry Edward Morrison
Garfield Paul Royer
Michael James Heller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BP Corp North America Inc
Original Assignee
BP Corp North America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BP Corp North America Inc filed Critical BP Corp North America Inc
Application granted granted Critical
Publication of DE3577230D1 publication Critical patent/DE3577230D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Networks Using Active Elements (AREA)
DE8585306916T 1984-09-27 1985-09-27 Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer. Expired - Fee Related DE3577230D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/656,011 US4804625A (en) 1984-09-27 1984-09-27 Assay procedures

Publications (1)

Publication Number Publication Date
DE3577230D1 true DE3577230D1 (de) 1990-05-23

Family

ID=24631279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585306916T Expired - Fee Related DE3577230D1 (de) 1984-09-27 1985-09-27 Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.

Country Status (5)

Country Link
US (1) US4804625A (de)
EP (1) EP0180327B1 (de)
JP (1) JPS61107158A (de)
AT (1) ATE52140T1 (de)
DE (1) DE3577230D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI853523A0 (fi) * 1985-09-13 1985-09-13 Labsystems Oy Foerfarande foer utfoering av immunobestaemningar med hjaelp av enzymstaempel.
DE3640318A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren und testtraeger zur bestimmung eines analyten
GB8724764D0 (en) * 1987-10-22 1987-11-25 Alcan Int Ltd Enzyme assay method
EP0347256A3 (de) * 1988-06-17 1990-07-11 Tosoh Corporation Verfahren zum Nachweis einer Substanz in einer Probe
AU647459B2 (en) * 1990-01-26 1994-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A method for quantitatively measuring collagenase
CA2055812A1 (en) * 1990-11-20 1992-05-21 Carl N. Skold Method of stabilizing enzyme conjugates
US6652808B1 (en) * 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6569382B1 (en) 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
CA2138382C (en) * 1992-07-07 2006-01-17 Wlodzimierz Mandecki Alkaline phosphatase enzymes having improved specific activity for use in indicator reagents
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
US6225059B1 (en) 1993-11-01 2001-05-01 Nanogen, Inc. Advanced active electronic devices including collection electrodes for molecular biological analysis and diagnostics
DE19539008A1 (de) 1995-10-19 1997-04-24 Boehringer Mannheim Gmbh Reagenz zum Nachweis und zur Isolierung von Kohlehydraten oder Glycanrezeptoren
US6706473B1 (en) 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
US6342397B1 (en) * 1998-06-04 2002-01-29 Erkki Soini Homogeneous biospecific assay using a solid phase, two-photon excitation and confocal fluorescence detection
US6368899B1 (en) 2000-03-08 2002-04-09 Maxwell Electronic Components Group, Inc. Electronic device packaging
CA2442074C (en) * 2001-03-28 2014-07-22 Heska Corporation Methods of detecting early renal disease in animals
WO2004084841A2 (en) * 2003-03-27 2004-10-07 Heska Corporation Novel anti-feline albumin antibodies and methods of detecting early renal disease
US20050208671A1 (en) * 2003-12-26 2005-09-22 Nof Corporation Method of analyzing the ratio of activation of terminals of polyoxyalkylene derivatives
US7828954B2 (en) * 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US20080166792A1 (en) * 2007-01-05 2008-07-10 Attar Amir J Detection of analytes in materials liquids using capillary colorimetric detection
US20090203149A1 (en) * 2008-02-13 2009-08-13 General Electric Company Enhanced methods for gas and/or vapor phase analysis of biological assays
CN106324251B (zh) * 2016-08-08 2019-03-29 上海睿康生物科技有限公司 小片段BMG抗体的制备方法及β2-微球蛋白检测试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407943A (en) * 1976-12-16 1983-10-04 Millipore Corporation Immobilized antibody or antigen for immunoassay
SE404553B (sv) * 1977-03-04 1978-10-09 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4277560A (en) * 1978-10-24 1981-07-07 Technicon Instruments Corporation Enzyme immunoassays using immobilized reagents in a flowing stream
SE7812237L (sv) * 1978-11-28 1980-05-29 Pharmacia Diagnostics Ab Koncentrationsbestemning av substanser med formaga att biospecifikt binda molekyler med biologiskt ursprung
US4576912A (en) * 1978-11-30 1986-03-18 Technicon Instruments Corporation Fluoroimmunoassaying
US4268663A (en) * 1979-04-10 1981-05-19 Syva Company Macromolecular glycosidase substrates
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4423143A (en) * 1980-12-30 1983-12-27 Syva Company β-D-Galactosidase conjugate for enzyme immunoassays
ATE17048T1 (de) * 1982-05-26 1986-01-15 Boots Celltech Diagnostics Immunoassay.
US4530900A (en) * 1982-09-13 1985-07-23 Seragen Diagnostics Inc. Soluble insoluble polymers in enzymeimmunoassay
US4629689A (en) * 1984-08-29 1986-12-16 Allied Corporation Binding assay with amplified read-out and gas-phase detection

Also Published As

Publication number Publication date
US4804625A (en) 1989-02-14
EP0180327B1 (de) 1990-04-18
EP0180327A1 (de) 1986-05-07
JPS61107158A (ja) 1986-05-26
ATE52140T1 (de) 1990-05-15

Similar Documents

Publication Publication Date Title
DE3577230D1 (de) Bestimmungsmethode unter einbeziehung einer phasentrennung und testsatz hierfuer.
ATE311591T1 (de) System zur elektrochemischen quantitativen analyse von analyten in einer festphase
Yulaev et al. Development of a potentiometric immunosensor for herbicide simazine and its application for food testing
DE3882040D1 (de) Verfahren und vorrichtungen zur durchfuehrung von untersuchungen.
DE69733560D1 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
CA2081559A1 (en) Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ATE175025T1 (de) Verfahren, reagenzien und testkits zum nachweis von subpopulationen biologischer substanzen
DE3580640D1 (de) Testverfahren.
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
ATE63167T1 (de) Heterogener spezifischer bindungstest unter verwendung eines anhaeufbaren bindungsreagens.
ATE101722T1 (de) Qualitativer enzymtest zur visuellen auswertung.
DK314987D0 (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
ATE210825T1 (de) Küvette für eine analysevorrichtung, verfahren und diagnostischer testsatz zur feststellung von analyten in vollblutproben
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
JPS57132060A (en) Peculiarly bonding protein and method of measuring one component in reaction of material able to be bonded thereto
DE69223651D1 (de) Vorrichtungen zur ausführung von ioneneinfangassays
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
Van den Besselaar et al. The use of evacuated tubes for blood collection in oral anticoagulant control
EP3404418A2 (de) Diagnostischer streifen zur bestimmung der menge an sarkosin, kreatinin und wasserstoffperoxid in einer biologischen oder umweltprobe
DK518189D0 (da) Antistofanalysereagens
DE69026497D1 (de) Verfahren zur prüfung von d-vanillylmandelsäure und reagenz und satz dafür
ATE80948T1 (de) Diagnostisches immuntest-verfahren mittels festphasenabscheidung.
SE7905266L (sv) Forfarande och testanordning for bestemning av karbamidhalten i vetskor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee